Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment

Introduction: Treatment options for neuroendocrine tumors (NETs) are rarely curative, as NETs frequently show resistance to medical therapy. The use of everolimus, an mTOR inhibitor, is limited by the development of resistance, probably due to the activation of Akt signaling. In this context, the an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Vitali, Eleonora, Boemi, Ilena, Tarantola, Giulia, Piccini, Sara, Zerbi, Alessandro, Veronesi, Giulia, Baldelli, Roberto, Mazziotti, Gherardo, Smiroldo, Valeria, Lavezzi, Elisabetta, Spada, Anna, Mantovani, Giovanna, Lania, Andrea G.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464161/
https://ncbi.nlm.nih.gov/pubmed/32748870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados